Using their proprietary SmartFinder and MultiFinder multiplex PCR technologies, PathoFinder enables rapid detection and identification of up to 22 human pathogens in clinical specimens. Their RealAccurate® products include Real Time PCR assays for targeted human infectious diseases such as respiratory tract infections, gastroenteritis, viral meningitis, sexually transmitted diseases, and human papillomavirus infections. PathoFinder's multiplex PCR products save time, allow for automation, and are cost-effective, making them ideal for integrating comprehensive molecular diagnostics into daily clinical routines. The company's ISO 13485:2003 certified environment ensures optimal quality, sensitivity, and specificity of their developed and produced products. With a focus on syndromic infectious disease panels, PathoFinder's RespiFinder test is widely used in leading hospitals across Europe, complying with CE-IVD guidelines.